DESCRIPTION A variety of treatment modalities are available to treat varicose veins/venous insufficiency, including surgical approaches, thermal ablation, and sclerotherapy. The application of each of these treatment options is influenced by the severity of the symptoms, the type of vein, the source of venous reflux, and the use of other (prior or concurrent) treatments.
The venous system of the lower extremities consists of the superficial veins (this includes the greater and lesser saphenous, and accessory or duplicate veins that travel in parallel with the greater and lesser saphenous veins), the deep system (popliteal and femoral veins), and perforator veins that cross through the fascia and connect the deep and superficial systems. One-way valves are present within all veins to direct the return of blood up the lower limb. Since venous pressure in the deep system is generally greater than that of the superficial system, valve incompetence at any level may lead to backflow (venous reflux) with pooling of blood in superficial veins. Varicose veins with visible varicosities may be the only sign of venous reflux, although itching, heaviness, tension, and pain may also occur. Chronic venous insufficiency secondary to venous reflux can lead to thrombophlebitis, leg ulcerations and hemorrhage. The CEAP classification considers the clinical, etiologic, anatomic, and pathologic characteristics of venous insufficiency, ranging from class 0 (no visible sign of disease) to class 6 (active ulceration).
Treatment of venous reflux/venous insufficiency is aimed at reducing abnormal pressure transmission from the deep to the superficial veins. Conservative medical treatment consists of elevation of the extremities, graded compression, and wound care when indicated. Conventional surgical treatment consists of identifying and correcting the site of reflux by ligation of the incompetent junction followed by stripping of the vein to redirect venous flow through veins with intact valves. While most venous reflux is secondary to incompetent valves at the saphenofemoral or saphenopopliteal junctions, reflux may also occur at incompetent valves in the perforator veins or in the deep venous system. The competence of any single valve is not static and may be pressure dependent. For example, accessory saphenous veins may have independent saphenofemoral or saphenopopliteal junctions which become incompetent when the greater or lesser saphenous veins are eliminated and blood flow is diverted through the accessory veins.
Saphenous Veins and Tributaries
Treatment of venous reflux typically includes the following:
- Identification by preoperative Doppler ultrasonography of the valvular incompetence
- Control of the most proximal point of reflux, traditionally by suture ligation of the incompetent saphenofemoral or saphenopopliteal junction
- Removal of the superficial vein from circulation, for example by stripping of the greater and/or lesser saphenous veins
- Removal of varicose tributaries (at the time of the initial treatment or subsequently) by stab avulsion (phlebectomy) or injection sclerotherapy.
Minimally invasive alternatives to ligation and stripping have been investigated. These include sclerotherapy, transilluminated powered phlebotomy, and thermal ablation using cryotherapy, high frequency radiowaves (200–300 kHz) or laser energy.
The objective of sclerotherapy is to destroy the endothelium of the target vessel by injecting an irritant solution (either a detergent, osmotic solution, or chemical irritant), ultimately resulting in the occlusion of the vessel. The success of the treatment depends on accurate injection of the vessel, an adequate injectate volume and concentration of sclerosant, and compression. Historically, larger veins and very tortuous veins were not considered to be good candidates for sclerotherapy due to technical limitations. Technical improvements in sclerotherapy have included the routine use of Duplex ultrasound to target refluxing vessels, luminal compression of the vein with anesthetics, and a foam/sclerosant injectate in place of liquid sclerosant. Foam sclerosants are produced by forcibly mixing a gas (air or carbon dioxide) with a liquid sclerosant (e.g., polidocanol or sodium tetradecyl sulfate). The foam is produced at the time of treatment and is considered an off-label use. A proprietary microfoam sclerosant (Varisolve, BTG PLC, London) with a controlled density and more consistent bubble sizes is being developed in Europe.
Radiofrequency ablation is performed by means of a specially designed catheter inserted through a small incision in the distal medial thigh to within 1–2 cm of the saphenofemoral junction. The catheter is slowly withdrawn, closing the vein. Laser ablation is performed similarly; a laser fiber is introduced into the greater saphenous vein under ultrasound guidance; the laser is activated and slowly removed along the course of the saphenous vein. Cryoablation uses extreme cold to cause injury to the vessel. The objective of endoluminal techniques is to cause injury to the vessel, causing retraction and subsequent fibrotic occlusion of the vein. Technical developments since thermal ablation procedures were initially introduced include the use of perivenous tumescent anesthesia, which allows successful treatment of veins larger than 12 mm in diameter and helps to protect adjacent tissue from thermal damage during treatment of the lesser saphenous vein.
Transilluminated Powered Phlebectomy
Transilluminated powered phlebectomy (TIPP) is an alternative to stab avulsion or hook phlebectomy. This procedure uses 2 instruments; an illuminator which also provides irrigation, and a resector which has an oscillating tip and can perform suction. Following removal of the saphenous vein, the illuminator is introduced via a small incision in the skin and tumescence solution (anesthetic and epinephrine) is infiltrated along the course of the varicosity. The resector is then inserted under the skin from the opposite direction, and the oscillating tip is placed directly beneath the illuminated veins to fragment and loosen the veins from the supporting tissue. Irrigation from the illuminator is used to clear the vein fragments and blood through aspiration and additional drainage holes. The illuminator and resector tips may then be repositioned, thereby reducing the number of incisions needed when compared with stab avulsion or hook phlebectomy. It has been proposed that TIPP might result in decreased operative time, decreased complications such as bruising, and faster recovery compared to the established procedures.
Treatment of Perforator Veins
Incompetent perforating veins were originally addressed with an open surgical procedure, called the Linton procedure, which involved a long medial calf incision to expose all posterior, medial, and paramedial perforators. While this procedure was associated with healing of ulcers, it was largely abandoned due to a high incidence of wound complications. The Linton procedure was subsequently modified by using a series of perpendicular skin flaps instead of a longitudinal skin flap to provide access to incompetent perforator veins in the lower part of the leg. The modified Linton procedure may be occasionally utilized for the closure of incompetent perforator veins that can not be reached by less invasive procedures. Subfascial endoscopic perforator surgery (SEPS) is a less invasive surgical procedure for treatment of incompetent perforators and has been reported since the mid-1980s. Guided by Duplex ultrasound scanning, small incisions are made in the skin and the perforating veins are clipped or divided by endoscopic scissors. The operation can be performed as an outpatient procedure. Endoluminal ablation of incompetent perforator veins with sclerotherapy and radiofrequency has also been reported.
Deep vein valve replacement is being investigated.
Outcomes of interest for venous interventions include healing and recurrence, recannulation of the vein, and neovascularization. Recannulation (recanalization) is the restoration of the lumen of a vein after it has been occluded; this occurs more frequently following treatment with endovenous techniques. Neovascularization is the proliferation of new blood vessels in tissue, and occurs more frequently following vein stripping. Direct comparisons of durability for endovenous and surgical procedures are complicated by these different mechanisms of recurrence. Relevant safety outcomes include the incidence of paresthesia, thermal skin injury, thrombus formation, thrombophlebitis, wound infection, and transient neurologic effects.
The following devices have received specific U.S. Food and Drug Administration (FDA) marketing clearance for the endovenous treatment of superficial vein reflux:
- In 1999, the VNUS® Closure™ system (a radiofrequency device) received FDA clearance through the 510(k) process for "endovascular coagulation of blood vessels in patients with superficial vein reflux." The VNUS RFS and RFSFlex devices received FDA clearance in 2005 for “use in vessel and tissue coagulation including: treatment of incompetent (i.e., refluxing) perforator and tributary veins. The modified VNUS® ClosureFAST™ Intravascular Catheter received FDA clearance through the 510(k) process in 2008.
- In 2002, the Diomed 810 nm surgical laser and EVLT™(endovenous laser therapy) procedure kit received FDA clearance through the 510(k) process, "In addition to the already cleared indications for use: for use in the endovascular coagulation of the greater saphenous vein of the thigh in patients with superficial vein reflux."
A modified Erbe Erbokryo® cryosurgical unit (Erbe USA) received FDA clearance for marketing in 2005. A variety of clinical indications are listed, including cryostripping of varicose veins of the lower limbs.
- The Trivex system is a device for transilluminated powered phlebectomy that received FDA clearance through the 510(k) process in October 2003. According to the label, the intended use is for “ambulatory phlebectomy procedures for the resection and ablation of varicose veins.”
- Varisolve® (BTG PLC, London) is a sclerosant microfoam made with a proprietary gas mix. A phase II safety study for the FDA has been completed. In late October 2009, the sponsor submitted a request to the FDA for a protocol assessment to agree on the design, endpoints and statistical analyses for the phase III trial.
POLICY Greater or Lesser Saphenous Veins
Treatment of the greater or lesser saphenous veins by surgery (ligation and stripping) or endoluminal radiofrequency or laser ablation may be considered medically necessary for symptomatic varicose veins/venous insufficiency when the following criteria have been met:
Treatment of greater or lesser saphenous veins by surgery or endoluminal radiofrequency or laser ablation that do not meet the criteria described above is considered cosmetic and not medically necessary.
Accessory Saphenous Veins
Treatment of accessory saphenous veins by surgery (ligation and stripping) or endoluminal radiofrequency or laser ablation may be considered medically necessary for symptomatic varicose veins/venous insufficiency when the greater or lesser saphenous veins have been previously eliminated and the following criteria have been met:
Treatment of accessory saphenous veins by surgery or endoluminal radiofrequency or laser ablation that do not meet the criteria described above is considered cosmetic and not medically necessary.
Symptomatic Varicose Tributaries
The following treatments are considered medically necessary as a component of the treatment of symptomatic varicose tributaries when performed either at the same time or following prior treatment (surgical, radiofrequency or laser) of the saphenous veins (none of these techniques has been shown to be superior to another):
- Stab avulsion
- Hook phlebectomy
- Transilluminated powered phlebectomy
Treatment of symptomatic varicose tributaries when performed either at the same time or following prior treatment of saphenous veins using any other techniques than noted above is considered investigational.
Surgical ligation (including SEPS) or endoluminal radiofrequency or laser ablation of incompetent perforator veins may be considered medically necessary as a treatment of leg ulcers associated with chronic venous insufficiency when the following conditions have been met:
- There is demonstrated perforator reflux; AND
- The superficial saphenous veins (greater, lesser, or accessory saphenous and symptomatic varicose tributaries) have been previously eliminated; AND
- Ulcers have not resolved following combined superficial vein treatment and compression therapy for at least 3 months; AND
- The venous insufficiency is not secondary to deep venous thromboembolism.
Ligation or ablation of incompetent perforator veins performed concurrently with superficial venous surgery is not medically necessary.
Treatment of telangiectasia such as spider veins, angiomata, and hemangiomata is considered cosmetic and not medically necessary.
Techniques for conditions not specifically listed above are investigational, including, but not limited to:
- Sclerotherapy of perforator, greater or lesser saphenous, or accessory saphenous veins
- Sclerotherapy of isolated tributary veins without prior or concurrent treatment of saphenous veins
- Stab avulsion, hook phlebectomy, or TIPP of perforator, greater or lesser saphenous, or accessory saphenous veins
- Endoluminal radiofrequency or laser ablation of tributary veins
- Endoluminal cryoablation of any vein
This is not intended to be a comprehensive list of codes. Some covered procedure codes have multiple descriptions.
The code(s) listed below are ONLY covered if the procedure is performed according to the "Policy" section of this document.
|36470||Injection of sclerosing solution; single vein|
|36471||Injection of sclerosing solution; multiple veins, same leg|
Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; first vein treated
|Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, radiofrequency; second and subsequent veins treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure)|
|36478||Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, laser; first vein treated |
|36479||Endovenous ablation therapy of incompetent vein, extremity, inclusive of all imaging guidance and monitoring, percutaneous, laser; second and subsequent veins treated in a single extremity, each through separate access sites (List separately in addition to code for primary procedure)|
|37500||Vascular endoscopy, surgical, with ligation of perforator veins, subfascial (SEPS)|
|37700||Ligation and division of long saphenous vein at saphenofemoral junction, or distal interruptions |
|37718||Ligation, division, and stripping, short saphenous vein |
|37722||Ligation, division, and stripping, long (greater) saphenous veins from saphenofemoral junction to knee or below|
|37735||Ligation and division and complete stripping of long or short saphenous veins with radical excision of ulcer and skin graft and/or interruption of communicating veins of lower leg, with excision of deep fascia|
|37760||Ligation of perforator veins, subfascial, radical (Linton type), including skin graft, when performed, open,1 leg |
|37761||Ligation of perforator vein(s), subfascial, open, including ultrasound guidance, when performed, 1 leg|
|37765||Stab phlebectomy of varicose veins, 1 extremity; 10-20 stab incisions |
|37766||Stab phlebectomy of varicose veins, 1 extremity; more than 20 incisions|
|37780||Ligation and division of short saphenous vein at saphenopopliteal junction (separate procedure) |
|37785||Ligation, division, and/or excision of varicose vein cluster(s), 1 leg |
|37799||Unlisted procedure, vascular surgery|
|93970||Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study |
|93971||Duplex scan of extremity veins including responses to compression and other maneuvers; unilateral or limited study |
Ligation and stripping of lower limb varicose veins
|39.92||Injection of sclerosing agent into vein|
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
|454.1||Varicose veins of lower extremities with inflammation|
|454.2||Varicose veins of lower extremities with ulcer and inflammation|
|454.8||Varicose veins of the lower extremities with other complications |
|459.81||Unspecified venous (peripheral) insufficiency|
|671.00||Varicose veins of legs complicating pregnancy and the puerperium, unspecified as to episode of care|
|671.01||Varicose veins of legs, with delivery, with or without mention of antepartum condition|
|671.02||Varicose veins of legs, with delivery, with mention of postpartum complication|
|671.03||Varicose veins of legs, antepartum|
|671.04||Varicose veins of legs, postpartum|
|707.10 - 707.12||Ulcer of lower limbs, except pressure ulcer code range|
This is not an all-inclusive list of non-covered procedure codes.
The code(s) listed below and ANY code not listed in the previous section are considered non-covered for this procedure.
Single or multiple injections of sclerosing solutions, spider veins (telangiectasia); limb or trunk
|36469||Single or multiple injections of sclerosing solutions, spider veins (telangiectasia); face|